Graph

Go Further without a booster

Reduce IR Boosters with DYANAVEL XR

Fewer end-of-dose crashes at 90 days1

In a real-world study, patients taking DYANAVEL® XR (amphetamine) experienced fewer end-of-dose crashes at 90 days, compared to other extended-release medications, including Adderall XR®, Vyvanse®, Focalin®, and Methylphenidate ER.1

The study found that the use of DYANAVEL XR is associated with two important things, separately. On one hand, it was linked to fewer end-of-dose crashes when the ADHD medication wears off. On the other hand, its use was associated with less IR booster use during the day, compared to other extended release medications, would not name specific meds as they were pooled into one category of ER stimulants. Can add specific meds into a footnote saying the ones that were included.

Should you expect more from your ADHD medication?

Start the Conversation!

Answer these questions to create a personalized doctor discussion guide for your next appointment.

My ADHD symptoms are worse in the afternoon and evening

I often feel my medication wearing off while I still have things to do

My ADHD medication sometimes works differently from day to day

I'd like better control of my ADHD symptoms

Select an answer

Fewer medications. Fewer disruptions.

It’s important to discuss how to take medications with your healthcare provider and take them as directed. If you can avoid taking multiple medications, it may result in:

Lower Costs Icon

Lower Costs

You pay for only one prescription

Fewer Mistakes Icon

Fewer Mistakes

One pill reduces the chance of missing or doubling a dose

More Focus Icon

More Focus

Less disruptions of trying to time IR doses1

More Simplicity Icon

More Simplicity

Maintain an easier medication routine

But how is it different?

Clinical studies of DYANAVEL XR will show you how it performed over a 13-hour period. You should review these with your healthcare provider, as well as the unique way that DYANAVEL XR is consistently released through the day.2-4

Learn about significant reduction in the need for IR at 90 days

SAVINGS, SUPPORT & Guaranteed Availability*

We want to make getting DYANAVEL XR as easy and inexpensive as possible! Learn about your options below!

DYANAVEL XR Savings Program

Eligible patients pay $25* per month with the DYANAVEL XR Savings Program

Get savings card

Or text TRIS to TRIS4U (874748)
for a Mobile Savings Card**

Get free, fast delivery, full patient support, and the lowest available price

Info for new patients
Get free, fast delivery

Stay in the know with all things DYANAVEL XR

Join the DYANAVEL XR community, and follow us on social media!

* Terms and Conditions apply.
** Mobile Terms and Conditions: TrisSavingsCard.com/terms. Message data rates may apply.

References: 1. Young, J.L., Powell, R.N., Powell, A. et al. Extended-release amphetamine (Dyanavel XR) is associated with reduced immediate-release supplementation in adults with ADHD, regardless of baseline patient variables: a retrospective cohort analysis of medical treatment records. BMC Psychiatry 25, 12 (2025). 2. Childress AC, Wigal SB, Brams MN, et al. Efficacy and safety of amphetamine extended-release oral suspension in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psycholpharmacol. 2018;28(5):306-313. 3. Pardo A, Kando JC, King TR, Rafla E, Herman BK. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. CNS Spectr. 2020;25(6):774-781. 4. Cutler AJ, Hanaie J. Understanding the delivery technology used in ADHD stimulant medications can help to individualize treatment. CNS Spectrums. 2025;30(1):e30.

Important Safety Information & Approved Use

DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.

See Additional Important Safety Information.

APPROVED USE

DYANAVEL® XR (amphetamine) is a central nervous system (CNS) stimulant prescription medicine used for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in people 6 years and older. DYANAVEL XR may help increase attention and decrease impulsiveness and hyperactivity in people with ADHD.

DYANAVEL XR is not recommended for use in children under 6 years of age with ADHD.

Important Safety Information

DYANAVEL® XR (amphetamine) is a federally controlled substance (CII) because it contains amphetamine that can be a target for people who abuse prescription medicines or street drugs. DYANAVEL XR has a high chance for abuse and misuse and may lead to substance use problems, including addiction. Keep DYANAVEL XR in a safe place to prevent abuse and misuse. Never give your DYANAVEL XR to anyone else because it may cause death or harm them. Selling or giving away DYANAVEL XR may harm others and is against the law.

Your healthcare provider should check you or your child's risk for abuse, misuse, and addiction before starting treatment with DYANAVEL XR and will monitor you or your child during treatment.

Tell your physician if you, your child, or any family members have ever abused or been dependent on alcohol prescription medicines, or street drugs.

DYANAVEL XR should not be taken if you or your child are allergic to amphetamine or any of the ingredients in DYANAVEL XR or are taking or have taken within the past 14 days an anti-depression medicine called a monoamine oxidase inhibitor or MAOI including the antibiotic linezolid and the intravenous medicine methylene blue. Ask your healthcare provider or pharmacist if you are not sure if you or your child take any of these medicines.

DYANAVEL XR can cause serious side effects including:

  • Risks for people with serious heart disease: Sudden death has happened in people who have heart defects or other serious heart disease. Before starting DYANAVEL XR, tell your healthcare provider if you or your child have any heart problems, heart disease, or heart defects.
    Call your healthcare provider or go to the nearest hospital emergency room right away if you or your child has any signs of heart problems such as chest pain, shortness of breath, or fainting during treatment with DYANAVEL XR.
  • Increase in blood pressure and heart rate.
    Your healthcare provider should check your or your child’s blood pressure and heart rate regularly during treatment with DYANAVEL XR.
  • Mental (psychiatric) problems, including new or worse behavior and thought problems, new or worse bipolar illness, new psychotic symptoms (such as hearing voices, or seeing or believing things that are not real) or new manic symptoms.
    Tell your healthcare provider about any mental problems you or your child have, or about a family history of suicide, bipolar illness, or depression. Call the doctor right away if there are any new or worsening mental symptoms during treatment with DYANAVEL XR, especially hearing voices, seeing or believing things that are not real, or new manic symptoms.
  • Circulation problems in fingers and toes (peripheral vasculopathy, including Raynaud’s phenomenon). Tell your healthcare provider if you or your child have numbness, pain, skin color change, or sensitivity to temperature in your fingers or toes.
    Call the doctor right away if you or your child have any signs of unexplained wounds appearing on fingers or toes during treatment with DYANAVEL XR.
  • New or worsening tics or worsening Tourette’s syndrome. Tell your healthcare provider if you or your child get any new or worsening tics or worsening Tourette’s syndrome during treatment with DYANAVEL XR.
  • Serotonin Syndrome. This problem may happen when DYANAVEL XR is taken with certain other medicines and may be life-threatening. Stop taking DYANAVEL XR and call your healthcare provider or go to the nearest hospital emergency room if you get symptoms such as agitation, hallucinations, coma, or other changes in mental status; fast heartbeat; sweating or fever; nausea, vomiting, diarrhea; high or low blood pressure; problems controlling movements or muscle twitching; muscle stiffness or tightness.
  • Slowing of growth (height and weight) in children. Children should have their height and weight checked often during treatment with DYANAVEL XR. Your healthcare provider may stop your child’s DYANAVEL XR treatment if they are not growing or gaining weight as expected.
  • It is not known if DYANAVEL XR will harm the unborn baby. There is a pregnancy registry for females who are exposed to DYANAVEL XR during pregnancy. The purpose of the registry is to collect information about the health of females exposed to DYANAVEL XR and their baby. If you or your child becomes pregnant during treatment with DYANAVEL XR, talk to your healthcare provider about registering with the National Pregnancy Registry for Psychostimulants at 1-866-961-2388 or visit https://womensmentalhealth.org/clinical-and-research-programs/pregnancyregistry/othermedications/.
  • DYANAVEL XR passes into breast milk. You or your child should not breastfeed during treatment with DYANAVEL XR. Tell your doctor if you are breastfeeding or plan to breastfeed.
  • The most common side effects of amphetamine products include:

    – dry mouth

    – decreased appetite

    – weight loss

    – stomach pain

    – nausea

    – trouble sleeping

    – restlessness

    – extreme mood changes

    – dizziness

    – increased heart rate

These are not all of the possible side effects of DYANAVEL XR.
Talk to your doctor if you or your child have any side effects that bother you or do not go away.
Avoid drinking alcohol while taking DYANAVEL XR.

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Please see Full Prescribing Information, including Boxed Warning about Abuse, Misuse and Addiction and Medication Guide.

up arrowTop